{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:33Z","timestamp":1790223393139,"version":"4.1.0"},"reference-count":42,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cutaneous T-cell lymphoma (CTCL) is a malignancy of skin-homing T cells. A major feature of CTCL is profound immunosuppression, such that patients with advanced mycosis fungoides or Se\u0301zary syndrome have been compared with patients with advanced HIV disease and are susceptible to opportunistic infection. The etiology of this immunosuppression is unclear. We analyzed peripheral blood T cells of patients with CTCL with stage I to IV disease, using a sensitive beta-variable complementarity-determining region 3 spectratyping approach. Our data revealed a profound disruption of the complexity of the T-cell repertoire, which was universally observed in patients with advanced disease (stages III and IV), and present in up to 50% of patients with early-stage disease (stages I and II). In most patients, multiple monoclonal and oligoclonal complementarity-determining region 3 (CDR3) spectratype patterns in many different beta-variable families were seen. Equally striking was a reduction of normal T cells (as judged by absolute CD4 counts) across multiple beta-variable families. In general, CTCL spectratypes were reminiscent of advanced HIV spectratypes published elsewhere. Taken together, these data are most consistent with a global assault on the T-cell repertoire in patients with CTCL, a process that can be observed even in early-stage disease. (Blood. 2003;102:4059-4066)<\/jats:p>","DOI":"10.1182\/blood-2003-04-1044","type":"journal-article","created":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:15:24Z","timestamp":1057018524000},"page":"4059-4066","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":138,"title":["Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma"],"prefix":"10.1182","volume":"102","author":[{"given":"Nikhil","family":"Yawalkar","sequence":"first","affiliation":[{"name":"From the Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Ferenczi","sequence":"additional","affiliation":[{"name":"From the Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Jones","sequence":"additional","affiliation":[{"name":"From the Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"From the Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Young","family":"Suh","sequence":"additional","affiliation":[{"name":"From the Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sadat","sequence":"additional","affiliation":[{"name":"From the Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Kupper","sequence":"additional","affiliation":[{"name":"From the Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222293725900_REF1","unstructured":"Ferenczi K, Kupper TS. Cutaneous lymphoma. In: Sober H, ed. Atlas of Clinical Oncology. Hamilton-London: BC Decker; 2000: 85-117."},{"key":"2020021222293725900_REF2","doi-asserted-by":"crossref","unstructured":"Edelson RL. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Ann N Y Acad Sci. 2001;941: 1-11.","DOI":"10.1111\/j.1749-6632.2001.tb03705.x"},{"key":"2020021222293725900_REF3","doi-asserted-by":"crossref","unstructured":"Russell-Jones R, Whittaker S. T-cell receptor gene analysis in the diagnosis of Sezary syndrome. J Am Acad Dermatol. 1999;41: 254-249.","DOI":"10.1016\/S0190-9622(99)70057-5"},{"key":"2020021222293725900_REF4","unstructured":"Rook AH, Gottlieb SL, Wolfe JT, et al. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis. Clin Exp Immunol. 1997;107(suppl 1): 16-20."},{"key":"2020021222293725900_REF5","doi-asserted-by":"crossref","unstructured":"Bagot M, Nikolova M, Schirm-Chabanette F, Wechsler J, Boumsell L, Bensussan A. Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas. Ann N Y Acad Sci. 2001;941: 31-38.","DOI":"10.1111\/j.1749-6632.2001.tb03708.x"},{"key":"2020021222293725900_REF6","doi-asserted-by":"crossref","unstructured":"Ferenczi K, Fuhlbrigge RC, Pinkus JL, Pinkus GS, Kupper TS. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol. 2002;119: 1405-1410.","DOI":"10.1046\/j.1523-1747.2002.19610.x"},{"key":"2020021222293725900_REF7","doi-asserted-by":"crossref","unstructured":"Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol. 1996;132: 1309-1313.","DOI":"10.1001\/archderm.1996.03890350051009"},{"key":"2020021222293725900_REF8","doi-asserted-by":"crossref","unstructured":"Scarisbrick JJ, Whittaker S, Evans AV, et al. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood. 2001;97: 624-630.","DOI":"10.1182\/blood.V97.3.624"},{"key":"2020021222293725900_REF9","doi-asserted-by":"crossref","unstructured":"Axelrod PI, Lorber B, Vonderheid EC. Infections complicating mycosis fungoides and Sezary syndrome. JAMA. 1992;267: 1354-1358.","DOI":"10.1001\/jama.1992.03480100060031"},{"key":"2020021222293725900_REF10","doi-asserted-by":"crossref","unstructured":"Rook AH, Heald P. The immunopathogenesis of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995;9: 997-1010.","DOI":"10.1016\/S0889-8588(18)30054-6"},{"key":"2020021222293725900_REF11","doi-asserted-by":"crossref","unstructured":"Scarisbrick JJ, Child FJ, Evans AV, Fraser-Andrews EA, Spittle M, Russell-Jones R. Secondary malignant neoplasms in 71 patients with Sezary syndrome. Arch Dermatol. 1999;135: 1381-1385.","DOI":"10.1001\/archderm.135.11.1381"},{"key":"2020021222293725900_REF12","unstructured":"Maslanka K, Piatek T, Gorski J, Yassai M. Molecular analysis of T cell repertoires. Spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. Hum Immunol. 1995;44: 28-34."},{"key":"2020021222293725900_REF13","doi-asserted-by":"crossref","unstructured":"Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today. 1995;16: 176-181.","DOI":"10.1016\/0167-5699(95)80117-0"},{"key":"2020021222293725900_REF14","doi-asserted-by":"crossref","unstructured":"Raaphorst FM, Schelonka RL, Rusnak J, Infante AJ, Teale JM. TCRBV CDR3 diversity of CD4+ and CD8+ T-lymphocytes in HIV-infected individuals. Hum Immunol. 2002;63: 51-60.","DOI":"10.1016\/S0198-8859(01)00361-5"},{"key":"2020021222293725900_REF15","doi-asserted-by":"crossref","unstructured":"Rieux-Laucat F, Bahadoran P, Brousse N, et al. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome. J Clin Invest. 1998;102: 312-321.","DOI":"10.1172\/JCI332"},{"key":"2020021222293725900_REF16","doi-asserted-by":"crossref","unstructured":"Signorini S, Pirovano S, Fiorentini S, et al. Restriction of T-cell receptor repertoires in idiopathic CD4+ lymphocytopenia. Br J Haematol. 2000;110: 434-437.","DOI":"10.1046\/j.1365-2141.2000.02166.x"},{"key":"2020021222293725900_REF17","doi-asserted-by":"crossref","unstructured":"Wu CJ, Chillemi A, Alyea EP, et al. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood. 2000;95: 352-359.","DOI":"10.1182\/blood.V95.1.352"},{"key":"2020021222293725900_REF18","doi-asserted-by":"crossref","unstructured":"Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin \u201csuperantigens\u201d with human T cells. Proc Natl Acad Sci U S A. 1989;86: 8941-8945.","DOI":"10.1073\/pnas.86.22.8941"},{"key":"2020021222293725900_REF19","doi-asserted-by":"crossref","unstructured":"Genevee C, Diu A, Nierat J, et al. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29\/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol. 1992;22: 1261-1269.","DOI":"10.1002\/eji.1830220522"},{"key":"2020021222293725900_REF20","doi-asserted-by":"crossref","unstructured":"Moss P, Charmley P, Mulvihill E, et al. The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris. J Invest Dermatol. 1997;109: 14-19.","DOI":"10.1111\/1523-1747.ep12276338"},{"key":"2020021222293725900_REF21","unstructured":"Hall BL, Finn OJ. PCR-based analysis of the T-cell receptor V beta multigene family: experimental parameters affecting its validity. Biotechniques. 1992;13: 248-257."},{"key":"2020021222293725900_REF22","doi-asserted-by":"crossref","unstructured":"Bragado R, Lauzurica P, Lopez D, Lopez de Castro JA. T cell receptor V beta gene usage in a human alloreactive response. Shared structural features among HLA-B27-specific T cell clones. J Exp Med. 1990;171: 1189-1204.","DOI":"10.1084\/jem.171.4.1189"},{"key":"2020021222293725900_REF23","doi-asserted-by":"crossref","unstructured":"Hand SL, Alter MD, Finn OJ. T cells receptor beta-chain repertoires are nonrandomly selected in responses to HLA-DR1. Transplantation. 1996;61: 1084-1094.","DOI":"10.1097\/00007890-199604150-00017"},{"key":"2020021222293725900_REF24","doi-asserted-by":"crossref","unstructured":"Wei S, Charmley P, Robinson MA, Concannon P. The extent of the human germline T-cell receptor V beta gene segment repertoire. Immunogenetics. 1994;40: 27-36.","DOI":"10.1007\/BF00163961"},{"key":"2020021222293725900_REF25","doi-asserted-by":"crossref","unstructured":"Pilch H, Hohn H, Freitag K, et al. Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis. Clin Diagn Lab Immunol. 2002;9: 257-266.","DOI":"10.1128\/CDLI.9.2.257-266.2002"},{"key":"2020021222293725900_REF26","unstructured":"Beers MH, Berkow R. The Merck Manual of Diagnosis and Therapy. Whitehouse Station, NJ: Merck & Co; 1999: 931-938."},{"key":"2020021222293725900_REF27","doi-asserted-by":"crossref","unstructured":"Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396: 643-649.","DOI":"10.1038\/25292"},{"key":"2020021222293725900_REF28","doi-asserted-by":"crossref","unstructured":"Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 1993;9: 138-141.","DOI":"10.1016\/0168-9525(93)90209-Z"},{"key":"2020021222293725900_REF29","doi-asserted-by":"crossref","unstructured":"Farace F, Orlanducci F, Dietrich PY, et al. T cell repertoire in patients with B chronic lymphocytic leukemia: evidence for multiple in vivo T cell clonal expansions. J Immunol. 1994;153: 4281-4290.","DOI":"10.4049\/jimmunol.153.9.4281"},{"key":"2020021222293725900_REF30","doi-asserted-by":"crossref","unstructured":"Kluin-Nelemans JC, Kester MG, Melenhorst JJ, et al. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood. 1996;87: 3795-3802.","DOI":"10.1182\/blood.V87.9.3795.bloodjournal8793795"},{"key":"2020021222293725900_REF31","doi-asserted-by":"crossref","unstructured":"Vega F, Luthra R, Medeiros LJ, et al. Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood. 1996;100: 3369-3373.","DOI":"10.1182\/blood.V100.9.3369"},{"key":"2020021222293725900_REF32","doi-asserted-by":"crossref","unstructured":"Tan RS, Butterworth CM, McLaughlin H, Malka S, Samman PD. Mycosis fungoides\u2014a disease of antigen persistence. Br J Dermatol. 1974;91: 607-616.","DOI":"10.1111\/j.1365-2133.1974.tb12449.x"},{"key":"2020021222293725900_REF33","doi-asserted-by":"crossref","unstructured":"Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today. 1995;16: 145-149.","DOI":"10.1016\/0167-5699(95)80132-4"},{"key":"2020021222293725900_REF34","doi-asserted-by":"crossref","unstructured":"Schwab R, Szabo P, Manavalan JS, et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol. 1997;158: 4493-4499.","DOI":"10.4049\/jimmunol.158.9.4493"},{"key":"2020021222293725900_REF35","doi-asserted-by":"crossref","unstructured":"Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to \u201cbenign monoclonal gammopathy.\u201d J Exp Med. 1994;179: 609-618.","DOI":"10.1084\/jem.179.2.609"},{"key":"2020021222293725900_REF36","doi-asserted-by":"crossref","unstructured":"Wack A, Cossarizza A, Heltai S, et al. Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol. 1998;10: 1281-1288.","DOI":"10.1093\/intimm\/10.9.1281"},{"key":"2020021222293725900_REF37","doi-asserted-by":"crossref","unstructured":"Jameson SC. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol. 2002;2: 547-556.","DOI":"10.1038\/nri853"},{"key":"2020021222293725900_REF38","doi-asserted-by":"crossref","unstructured":"Hatzakis A, Touloumi G, Karanicolas R, et al. Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet. 2000;355: 599-604.","DOI":"10.1016\/S0140-6736(99)10311-8"},{"key":"2020021222293725900_REF39","doi-asserted-by":"crossref","unstructured":"McCormack JE, Callahan JE, Kappler J, Marrack PC. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol. 1993;150: 3785-3792.","DOI":"10.4049\/jimmunol.150.9.3785"},{"key":"2020021222293725900_REF40","doi-asserted-by":"crossref","unstructured":"Jackow CM, Cather JC, Hearne V, Asano AT, Musser JM, Duvic M. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion. Blood. 1997;89: 32-40.","DOI":"10.1182\/blood.V89.1.32"},{"key":"2020021222293725900_REF41","doi-asserted-by":"crossref","unstructured":"Pancake BA, Zucker-Franklin D, Coutavas EE. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease: a study of 50 patients. J Clin Invest. 1995;95: 547-554.","DOI":"10.1172\/JCI117697"},{"key":"2020021222293725900_REF42","doi-asserted-by":"crossref","unstructured":"Bazarbachi A, Soriano V, Pawson R, et al. Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol. 1997;98: 927-933.","DOI":"10.1046\/j.1365-2141.1997.3213138.x"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/12\/4059\/1692312\/h82303004059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/12\/4059\/1692312\/h82303004059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T06:47:10Z","timestamp":1704869230000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/102\/12\/4059\/16727\/Profound-loss-of-Tcell-receptor-repertoire"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,1]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-04-1044","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,1]]}}}